Benlysta (Belimumab)
Benlysta (Belimumab)
Benlysta (Belimumab) is a prescription medication used to treat certain forms of lupus, including systemic lupus erythematosus (SLE) and lupus nephritis. It works by targeting a protein in the immune system that is believed to play a role in the abnormal immune response seen in lupus. Benlysta helps reduce disease activity, flare-ups, and the need for steroids, offering long-term relief and better disease control when used alongside standard therapy.
Why Choose Benlysta (Belimumab)?
- Specifically designed for treating systemic lupus erythematosus (SLE) and lupus nephritis
- Helps reduce lupus flares and disease activity
- Can minimize reliance on corticosteroids
- Available in both intravenous (IV) and subcutaneous (SC) formulations for flexible treatment
- Clinically proven to improve patient-reported quality of life over time
How to Use Benlysta (Belimumab)?
- Always use Benlysta exactly as prescribed by your healthcare provider
- For IV use, treatment is administered by a healthcare professional at a medical facility
- For SC use, it is typically injected once a week at home – ensure you’re trained properly before self-injecting
- Store the medication in the refrigerator and protect it from light; do not freeze
- Allow the medication to reach room temperature before injecting
- Rotate injection sites to avoid skin irritation
- Do not miss doses; if you do, contact your doctor for instructions
Important Safety Information about Benlysta
- Benlysta is not recommended for people with severe active central nervous system lupus
- Inform your doctor if you have an active infection or a history of chronic infections before starting
- May increase your risk of serious infections and allergic reactions
- Tell your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding
- Live vaccines should be avoided during treatment with Benlysta
- Regular monitoring and follow-up appointments are important to ensure safe and effective use
Fact Table
| Facts | Details |
| Brand Name | Benlysta |
| Generic Name | Belimumab |
| Drug Class | Monoclonal antibody (BLyS-specific inhibitor) |
| Used For | Systemic Lupus Erythematosus (SLE), Lupus Nephritis |
| Route of Administration | Intravenous (IV) infusion or Subcutaneous (SC) injection |
| Dosage Form | Solution for injection |
| Typical Dosage | IV: 10 mg/kg every 2 weeks for 3 doses, then every 4 weeks
SC: 200 mg once weekly |
| How it Works | Inhibits B-lymphocyte stimulator (BLyS), reducing abnormal B-cell activity |
| Onset of Action | May take several weeks to notice improvement |
| Storage Requirements | Refrigerate at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light |
| Prescription Required | Yes |
| Availability at PharmaServe | Yes, Available via prescription with fast delivery and secure checkout |
Common Side Effects
Like all medications, Benlysta (Belimumab) can cause side effects, although not everybody gets them. Understanding these side effects can help you use this medication safely and effectively.
- Nausea
- Diarrhea
- Fever
- Insomnia (trouble sleeping)
- Nasal congestion or sore throat
If you experience any side effects, discuss them with your healthcare provider. They can offer advice and may adjust your treatment if necessary. Report any severe or unexpected side effects immediately.
How Can You Buy Benlysta (Belimumab)?
You can order Benlysta (Belimumab) using these methods on our website:
- Order Online
- Order by Phone
- Order by Fax
- Order your refills
Visit our How to order page.
